Inhibition of influenza H5N1 invasion by modified heparin derivatives-Reference-Cited by-同舟云学术

Inhibition of influenza H5N1 invasion by modified heparin derivatives

Published:2015 Issue:4 Volume:6 Page:640-646
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Skidmore Mark A.¹²³⁴⁵,Kajaste-Rudnitski Anna⁶⁷⁸⁹,Wells Nicola M.¹²³⁴,Guimond Scott E.¹²³⁴,Rudd Timothy R.¹⁰¹¹⁴¹²,Yates Edwin A.¹²³⁴,Vicenzi Elisa¹²¹³¹⁴¹⁵⁹

Affiliation:

1. Department of Biochemistry

2. Institute of Integrative Biology

3. University of Liverpool

4. UK

5. School of Life Sciences

6. San Raffaele Telethon Institute for Gene Therapy (TIGET)

7. and Division of Regenerative Medicine, Stem Cells and Gene Therapy

8. Milan

9. Italy

10. Diamond Light Source Ltd

11. Didcot

12. Viral Pathogens and Biosafety Unit

13. Division of Immunology, Transplantation and Infectious Diseases

14. San Raffaele Scientific Institute

15. Milano

Abstract

Chemically modified heparin derivatives offer a potential source of effective inhibitors of viral attachment, which are suitable for further optimisation.

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2015/MD/C4MD00516C

Reference44 articles.

1. Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases

2. Epidemiology and pathogenesis of influenza

3. Comparison of the Mutation Rates of Human Influenza A and B Viruses

4. Production of Common Colds in Human Volunteers by Influenza C Virus

5. Clinical Features of Influenza C Virus Infection in Children

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects;International Journal of Biological Macromolecules;2024-03

2. Research Progress on Antiviral Activity of Heparin;Current Medicinal Chemistry;2024-01

3. Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells;Pharmaceuticals;2023-09-29

4. Pediatric adenovirus pneumonia: clinical practice and current treatment;Frontiers in Medicine;2023-07-05

5. Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses;Scientific Reports;2023-03-23